Gene · 6500
Papers4,444
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 4,444
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| OLOGRAM-MODL: mining enriched n-wise combinations of genomic features with Monte Carlo and dictionary learning. | NAR Genom Bioinform | 2021 | 34988437 | PubTator, text mining | PubMed |
| Prognostic values of the core components of the mammalian circadian clock in prostate cancer. | PeerJ | 2021 | 34966582 | PubTator, text mining | PubMed |
| Progress on Poxvirus E3 Ubiquitin Ligases and Adaptor Proteins. | Front Immunol | 2021 | 34956175 | PubTator, text mining | PubMed |
| Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis. | Clin Transl Med | 2021 | 34954904 | PubTator, text mining | PubMed |
| FBXO22 Promotes Growth and Metastasis and Inhibits Autophagy in Epithelial Ovarian Cancers via the MAPK/ERK Pathway. | Front Pharmacol | 2021 | 34950036 | PubTator, text mining | PubMed |
| Regulation of Hedgehog Signal Transduction by Ubiquitination and Deubiquitination. | Int J Mol Sci | 2021 | 34948134 | PubTator, text mining | PubMed |
| Fungal Secondary Metabolites as Inhibitors of the Ubiquitin-Proteasome System. | Int J Mol Sci | 2021 | 34948102 | PubTator, text mining | PubMed |
| Take a Break to Repair: A Dip in the World of Double-Strand Break Repair Mechanisms Pointing the Gaze on Archaea. | Int J Mol Sci | 2021 | 34948099 | PubTator, text mining | PubMed |
| Huntingtin Ubiquitination Mechanisms and Novel Possible Therapies to Decrease the Toxic Effects of Mutated Huntingtin. | J Pers Med | 2021 | 34945781 | PubTator, text mining | PubMed |
| The Hippo Signaling Pathway in Cancer: A Cell Cycle Perspective. | Cancers (Basel) | 2021 | 34944834 | PubTator, text mining | PubMed |
| Potential of E3 Ubiquitin Ligases in Cancer Immunity: Opportunities and Challenges. | Cells | 2021 | 34943817 | PubTator, text mining | PubMed |
| Long Noncoding RNA and Circular RNA Expression Profiles of Monocyte-Derived Dendritic Cells in Autoimmune Hepatitis. | Front Pharmacol | 2021 | 34938195 | PubTator, text mining | PubMed |
| Establishment of Sunitinib-Resistant Xenograft Model of Renal Cell Carcinoma and the Identification of Drug-Resistant Hub Genes and Pathways. | Drug Des Devel Ther | 2021 | 34938069 | PubTator, text mining | PubMed |
| Pathogen-Host Interaction Repertoire at Proteome and Posttranslational Modification Levels During Fungal Infections. | Front Cell Infect Microbiol | 2021 | 34926320 | PubTator, text mining | PubMed |
| Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment. | Signal Transduct Target Ther | 2021 | 34924561 | PubTator, text mining | PubMed |
| CD95/Fas suppresses NF-κB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism. | iScience | 2021 | 34917906 | PubTator, text mining | PubMed |
| Comparative transcriptome and metabolome analysis reveal glutathione metabolic network and functional genes underlying blue and red-light mediation in maize seedling leaf. | BMC Plant Biol | 2021 | 34906076 | PubTator, text mining | PubMed |
| Prognostic value of CDCA3 in kidney renal papillary cell carcinoma. | Aging (Albany NY) | 2021 | 34905505 | PubTator, text mining | PubMed |
| Cyclin E/CDK2: DNA Replication, Replication Stress and Genomic Instability. | Front Cell Dev Biol | 2021 | 34901021 | PubTator, text mining | PubMed |
| A Comprehensive Review of the Potential Use of Green Tea Polyphenols in the Management of COVID-19. | Evid Based Complement Alternat Med | 2021 | 34899956 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6500/papers?page=47